Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

In Vitro Tests For Workplace Cocarcinogens, Final Report.

Authors
Barfknecht-TR; Hall-ME
Source
NIOSH 1984 May:266 pages
Link
NIOSHTIC No.
00134918
Abstract
An in-vitro study of known carcinogens was conducted. Compounds were evaluated for their ability to inhibit metabolic cooperation in an assay system consisting of wild type and mutant (HGPRT-) Chinese-V- 79-hamster cells. Mezerein (34807415), and 12-O- tetradecanoylphorbol-13-acetate (544638) strongly inhibited metabolic cooperation. Sodium-saccharin (128449), sodium- phenobarbital (57307), phorbol (17673255), butylated-hydroxytoluene (128370), butylated-hydroxyanisole (25013165), tert-butyl- hydroperoxide (75912), hydrogen-peroxide (7722841), benzoyl-peroxide (94360), and 2,4-dinitrofluorobenzene (70348) did not inhibit metabolic cooperation. Sodium-cyclamate (139059), tryptophan (153946), and amobarbital (57432) showed ambiguous or weakly positive results. The authors conclude that from comparison of results with those of in-vivo cancer bioassays, the Chinese-V-79- hamster cell assay system correctly identifies tumor promoting ability. The system is most effective in detecting known skin cancer promoters; however, the rate of false negative results is high (50 percent). Further research is recommended to improve the assay system so it can detect weak and non skin tumor promoters and to reduce the number of false negative responses.
Keywords
NIOSH-Contract; Carcinogenicity; In-vitro-studies; Clinical-chemistry; Animal-studies; Bioassays; Chemical-properties; Biological-effects; Biochemical-tests; Metabolic-study; Contract-200-82-2545;
CAS No.
34807-41-5; 544-63-8; 128-44-9; 57-30-7; 17673-25-5; 128-37-0; 25013-16-5; 75-91-2; 7722-84-1; 94-36-0; 70-34-8; 139-05-9; 153-94-6; 57-43-2;
Publication Date
19840510
Funding Type
Contract;
Fiscal Year
1984
NTIS Accession No.
PB84-243500
NTIS Price
A13
Identifying No.
Contract-200-82-2545
NIOSH Division
DBBS;
Source Name
Division of Biomedical and Behavioral Sciences, NIOSH, U.S. Department of Health and Human Services, Cincinnati, Ohio
State
OH;
TOP